SCHEMBL3395698

SCHEMBL3395698

Cc1ccnc(NC(O)c2c(-c3ccc(Cl)cc3Cl)nc3cc(C)ccn23)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 1/20 0.38
SYK P43405 1/20 0.37
POLB P06746 2/20 0.37
NPC1 O15118 1/20 0.36
CRHR1 P34998 2/20 0.36
IDH1 O75874 1/20 0.36
MAPT P10636 2/20 0.36
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35
FDPS P14324 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
DPP4 P27487 1/20 0.35
EGLN2 Q96KS0 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
MDM2 Q00987 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15879650 0.89 SMN1; SMN2 (0.43) SYKPOLBNPC1MAPTFDPS
SCHEMBL14632155 0.88 EGLN2 (0.39) NPC1CRHR1MAPTPIK3CAPIK3CB
SCHEMBL3433131 0.83 MDM2 (0.41) PHGDHSYKPOLBMAPTFDPS
SCHEMBL3396205 0.81 ALOX5 (0.44) SYKPOLBNPC1MAPTFDPS
SCHEMBL3391489 0.78 DPP4 (0.50) POLBNPC1CRHR1MAPTKDM4E
SCHEMBL3388535 0.75 MAPK14 (0.35) POLBMAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL3396264 0.74 CRHR1 (0.38) POLBCRHR1MAPTALDH1A1DPP4
SCHEMBL3393141 0.74 SLC34A1 (0.33)
SCHEMBL3395179 0.71 TRPA1 (0.38) NPC1CRHR1MAPTFDPSSMN1; SMN2
SCHEMBL1691373 0.71 DPP4 (0.53) POLBNPC1MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS BIOVITRUM AB (PUBL) (SE) 2015-08-27 US disclosed
US-20140206662-A1 Imidazopyridine Compounds PROXIMAGEN LTD. (GB) 2014-07-24 US disclosed
EP-2376490-B1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD (GB) 2013-01-23 EP disclosed
WO-2010064020-A1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD. (GB) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS SSB, MIF, IDO1 PHGDH 2696/4885SYK 408/4885POLB 1485/4885
US-20140206662-A1 Imidazopyridine Compounds SSB, NFKBIA, TPMT PHGDH 3110/4885SYK 221/4885POLB 1506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.